Signal Transducer and Activator of Transcription 3 Signaling Pathway: A Potential Target in Sarcoma Treatment
Journal:
Current Enzyme Inhibition
Volume:
6
Page:
105-117
Author(s):
Michiro Susa, Francis J. Hornicek, Xianzhe Liu and Zhenfeng Duan
ZD6474, a Small Molecule Tyrosine Kinase Inhibitor, Potentiates the Anti-Tumor and Anti-Metastasis Effects of Radiation for Human Nasopharyngeal Carcinoma
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
611-622
Author(s):
S. Yang, J. Wu, Y. Zuo, L. Tan, H. Jia, H. Yan, X. Zhu, M. Zeng, J. Ma and W. Huang
Recent Advances on the Possible Neuroprotective Activities of Epstein- Barr Virus Oncogene BARF1 Protein in Chronic Inflammatory Disorders of Central Nervous System
Journal:
Current Neuropharmacology
Volume:
8
Page:
268-275
Author(s):
Alicia Wynne, Rupinder K. Kanwar, Rajiv Khanna and Jagat R. Kanwar
Bcl-2 Family Proteins as Therapeutic Targets
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
3132-3148
Author(s):
Peter E. Czabotar and Guillaume Lessene
The Potential of Tetrandrine Against Gliomas
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
10
Page:
534-542
Author(s):
Yun Chen and Sheng-Hong Tseng
New Strategies and Patent Therapeutics in EBV-Associated Diseases
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
10
Page:
914-927
Author(s):
E. Villegas, O. Santiago, A. Sorlozano and J. Gutierrez
Targeting Thioredoxin Reductase: Anticancer Agents and Chemopreventive Compounds
Journal:
Medicinal Chemistry
Volume:
6
Page:
286-297
Author(s):
H. H. Zeng and L. H. Wang
Long-Term Immunovirogical Effect and Tolerability of a Maraviroc- Containing Regimen in Routine Clinical Practice
Journal:
Current HIV Research
Volume:
8
Page:
482-486
Author(s):
Miguel Genebat, Ezequiel Ruiz-Mateos, Ildefonso Pulido, Alejandro Gonzalez-Serna, Antonio Garcia-Perganeda, Gema Mendez, Maria Concepcion Romero-Sanchez, Sara Ferrando-Martinez and Manuel Leal
The Human Microbiome Project, Personalized Medicine and the Birth of Pharmacomicrobiomics
Journal:
Current Pharmacogenomics and Personalized Medicine
Volume:
8
Page:
182-193
Author(s):
Mariam Reyad Rizkallah, Rama Saad and Ramy Karam Aziz
Double-Blind, Controlled Phase II Study of a 5-HT6 Receptor Antagonist, SB-742457, in Alzheimers Disease
Journal:
Current Alzheimer Research
Volume:
7
Page:
374-385
Author(s):
G. Maher-Edwards, M. Zvartau-Hind, A.J. Hunter, M. Gold, G. Hopton, G. Jacobs, M. Davy and P. Williams